Living with Glucose-6-Phosphate Dehydrogenase Deficiency
Abstract
Glucose-6-phosphate dehydrogenase deficiency (G6PD deficiency) is an X-linked recessive hereditary disease characterized by abnormally low levels of glucose-6-phosphate dehydrogenase, a metabolic enzyme involved in the pentose phosphate pathway, especially important in red blood cell metabolism. G6PD deficiency is the most common human enzyme defect. Individuals with this disease may exhibit non-immune hemolytic anemia in response to a number of causes, most commonly infection or exposure to certain medications or fava beans. G6PD deficiency is closely linked to a disorder characterized by a hemolytic reaction to the consumption of fava or broad beans, with a name derived from the Italian name of the broad bean (fava). This type of anemia leads to paleness, yellowing of the skin and whites of the eyes (jaundice), dark urine, fatigue, shortness of breath and a rapid heart rate. It has been proposed that G6PD deficiency provides protection against malaria. Some babies with G6PD deficiency may have jaundice for longer than usual in the first month of life. Most people with G6PD deficiency have a completely normal life as long as they avoid certain foods and drugs. Keywords: G6PD deficiency, X-linked, pentose phosphate pathway (PPP), hemolytic anemia, favism Cite this Article Akoijam Sangita Devi, Malar Kodi, Akoijam Mamata Devi et al. Living with Glucose-6-Phosphate Dehydrogenase Deficiency. Journal of Nursing Science and Practice. 2016; 6(1): 23–30p.Veröffentlicht
Ausgabe
Rubrik
Lizenz
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
· I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
· I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
· I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
· I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
_______________
We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |